Stifel Canada cut shares of Centric Health (TSE:CRX – Free Report) from a strong-buy rating to a hold rating in a report released on Monday morning, Zacks.com reports. Stifel Canada also issued estimates for Centric Health’s FY2024 earnings at $0.02 EPS.
Separately, Ventum Cap Mkts upgraded shares of Centric Health to a strong-buy rating in a research report on Thursday, August 8th.
Centric Health Stock Performance
Further Reading
- Five stocks we like better than Centric Health
- Technology Stocks Explained: Here’s What to Know About Tech
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- What is the Nikkei 225 index?
- Jeff Brown’s Exegesis AI Stock Picks
- What are earnings reports?
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
